Wednesday, November 13, 2013 12:37:52 PM
Recent SUPN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 09:19:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:13:12 PM
- Supernus Announces Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/04/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/01/2024 08:35:56 PM
- Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024 • GlobeNewswire Inc. • 10/31/2024 08:10:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:38:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 08:48:11 PM
- Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/21/2024 08:25:48 PM
- iPhone 16 Sales in China Up 20%; Sobr Safe Jumps 108% Pre-Market; Netflix and Intuitive Surgical Beat Estimates • IH Market News • 10/18/2024 10:09:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:16:40 PM
- Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder • GlobeNewswire Inc. • 10/17/2024 08:05:25 PM
- Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder • GlobeNewswire Inc. • 10/10/2024 09:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 09:03:28 PM
- Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree • GlobeNewswire Inc. • 09/24/2024 11:30:33 AM
- Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit • GlobeNewswire Inc. • 09/19/2024 08:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 09:00:12 PM
- Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 11:03:01 AM
- Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA • GlobeNewswire Inc. • 08/19/2024 11:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:18:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:16:00 PM
- Supernus Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:06:00 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM